Inhibiting Mutant Isocitrate Dehydrogenase 1 (mIDH-1)
Copyright © Targeted News Service 2024
2024-04-23
ALEXANDRIA, Virginia, April 24 -- FORMA THERAPEUTICS, INC., Watertown, Massachusetts has been assigned a patent (No. US 11963956 B2, initially filed March 21, 2022) developed by seven inventors Patrick F. Kelly, Concord, Massachusetts; Susan Ashwell, Carlisle, Massachusetts; Blythe Thomson, Cincinnati, Ohio; Alan Collis, Lexington, Massachusetts; Jeff Davis, Hingham, Massachusetts; Duncan Walker, Boulder, Colorado; and Wei Lu, Newton, Massachusetts, for "Inhibiting mutant isocitrate dehydrogena . . .